The company manufactures non-standard peptides for pharmaceutical use as APIs and will operate a factory with a floor area of over 10,000 m2 in the Settsu factory of Shionogi & Co., which is also a shareholder, from autumn of 2019. An R & D laboratory will also be established, and 20 to 30 technicians will be stationed. PeptiStar is financially supported by INCJ, the innovation network corporation of Japan. INCJ was established in 2009 as a public-private investment company that provides financial, technological and management support for next-generation businesses. INCJ specifically supports those projects that combine technologies and varied expertise across industries and materialize open innovation. INCJ has the capacity to invest up to JPY2 trillion (approx. US$20 billion).

Nikkei Biotech news release, May 29, 2018